Cargando…

The duration of endocrine therapy and breast cancer patients’ survival: A nationwide population-based cohort study

As research progressed, the recommended duration of endocrine therapy for breast cancer patients has been extended from 5 to 10 years. This study aimed to investigate how the duration of endocrine medication and therapy affect survival rate in the real world. By using the National Health Insurance R...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chang, Chuan-Hsun, Huang, Chun-Wen, Huang, Chien-Ming, Ou, Tzu-Chi, Chen, Chu-Chieh, Lu, You-Min
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2019
Materias:	5750
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6824710/ https://www.ncbi.nlm.nih.gov/pubmed/31651908 http://dx.doi.org/10.1097/MD.0000000000017746

Ejemplares similares

Endocrine therapies in postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2-negative, pretreated, advanced breast cancer: A network meta-analysis
por: Lee, Cho-Hao, et al.
Publicado: (2020)

An app to classify a 5-year survival in patients with breast cancer using the convolutional neural networks (CNN) in Microsoft Excel: Development and usability study
por: Lin, Cheng-Yao, et al.
Publicado: (2022)

Efficacy and safety of endocrine monotherapy as first-line treatment for hormone-sensitive advanced breast cancer: A network meta-analysis
por: Zhang, Jingwen, et al.
Publicado: (2017)

Influence of occupation and education level on breast cancer stage at diagnosis, and treatment options in China: A nationwide, multicenter 10-year epidemiological study
por: Liu, Yang, et al.
Publicado: (2017)

Adjuvant endocrine therapy alone in patients with node-positive, luminal A type breast cancer
por: Park, Sungmin, et al.
Publicado: (2017)

Association between depressive disorders and risk of breast cancer recurrence after curative surgery
por: Chen, Shaw-Ji, et al.
Publicado: (2016)

Impact of patient race and geographical factors on initiation and adherence to adjuvant endocrine therapy in medicare breast cancer survivors
por: Camacho, Fabian T., et al.
Publicado: (2017)

Real-world effectiveness and sensitivity of palbociclib plus endocrine therapy in HR+/HER2– patients with metastatic breast cancer
por: Li, Jingping, et al.
Publicado: (2021)

Neoadjuvant chemotherapy combined with endocrine therapy for hormone receptor-positive breast cancer: A systematic review and meta-analysis
por: Ma, Hong-Fang, et al.
Publicado: (2023)

The association between methods of biopsy and survival following breast cancer: A hospital registry based cohort study
por: Kong, Yek-Ching, et al.
Publicado: (2020)

Characterization of Korean Male Breast Cancer Using an Online Nationwide Breast-Cancer Database: Matched-Pair Analysis of Patients With Female Breast Cancer
por: Choi, Min-Young, et al.
Publicado: (2016)

Bacterial extracellular vesicles affect endocrine therapy in MCF7 cells
por: An, Jeongshin, et al.
Publicado: (2021)

Treatment and survival patterns of Chinese patients diagnosed with breast cancer between 2005 and 2009 in Southwest China: An observational, population-based cohort study
por: Peng, Zuxiang, et al.
Publicado: (2016)

Conditional disease-free survival among patients with breast cancer
por: Paik, Hyun-June, et al.
Publicado: (2017)

Utility of Red Cell Distribution Width as a Prognostic Factor in Young Breast Cancer Patients
por: Huang, Du-Ping, et al.
Publicado: (2016)

Prognostic Significance of Preoperative Circulating Monocyte Count in Patients With Breast Cancer: Based on a Large Cohort Study
por: Wen, Jiahuai, et al.
Publicado: (2015)

Effect of aspirin use on survival benefits of breast cancer patients: A meta-analysis
por: Liu, Jiamin, et al.
Publicado: (2021)

Amplification of HER2 and TOP2A and deletion of TOP2A genes in a series of Taiwanese breast cancer
por: Chen, Jim-Ray, et al.
Publicado: (2017)

Magnetic resonance imaging and contrast-enhanced ultrasound findings of a recurrent primary breast angiosarcoma: A case report
por: Yang, Ou Ou, et al.
Publicado: (2021)

Better survival in PMRT of female breast cancer patients with >5 negative lymph nodes: A population-based study
por: Wang, Haiyong, et al.
Publicado: (2017)

Impact of WNT1-inducible signaling pathway protein-1 (WISP-1) genetic polymorphisms and clinical aspects of breast cancer
por: Wang, Yan, et al.
Publicado: (2019)

The Extent of Axillary Surgery Is Associated With Breast Cancer-specific Survival in T1–2 Breast Cancer Patients With 1 or 2 Positive Lymph Nodes: A SEER-Population Study
por: Li, Shunrong, et al.
Publicado: (2016)

Clinical study of combined application of indocyanine green and methylene blue for sentinel lymph node biopsy in breast cancer
por: Zhang, Chenguang, et al.
Publicado: (2021)

Association between miR-27a rs895819 polymorphism and breast cancer susceptibility: Evidence based on 6118 cases and 7042 controls
por: Liu, Yuan, et al.
Publicado: (2021)

Physical and psychological effects of different temperature-controlled breast prostheses on patients with breast cancer during rehabilitation: a randomized controlled study (CONSORT)
por: Qiu, Jiajia, et al.
Publicado: (2020)

Background Parenchymal Enhancement on Preoperative Magnetic Resonance Imaging: Association With Recurrence-Free Survival in Breast Cancer Patients Treated With Neoadjuvant Chemotherapy
por: Choi, Ji Soo, et al.
Publicado: (2016)

Can we cure stage IV triple-negative breast carcinoma?: Another case report of long-term survival (7 years)
por: Chue, Ben Man-Fai, et al.
Publicado: (2019)

Prediction of postoperative survival of triple-negative breast cancer based on nomogram model combined with expression of HIF-1α and c-myc
por: Cui, Jianxiu, et al.
Publicado: (2019)

The effects of LncRNA PVT1 on clinical characteristics and survival in breast cancer patients: A protocol for systematic review and meta analysis
por: Xie, Li, et al.
Publicado: (2021)

Mucoepidermoid carcinoma of the breast, 3 cases report and literature review
por: He, Xin, et al.
Publicado: (2023)

Efficacy of fulvestrant 500 mg in Chinese postmenopausal women with advanced/recurrent breast cancer and factors associated with prolonged time-to-treatment failure: A retrospective case series
por: Huang, Jian, et al.
Publicado: (2020)

Primary tumor resection for initially staged IV breast cancer: An emphasis on programmed death-ligand 1 expression, promoter methylation status, and survival
por: Erol, Timuçin, et al.
Publicado: (2019)

Prognostic significance of molecular subtype, metastatic site and primary tumor surgery for survival in primary metastatic breast cancer: A SEER-based study
por: Li, Yang, et al.
Publicado: (2021)

Rethinking on the management strategy of malignant phyllodes tumor of the breast: An analysis based on the SEER database
por: Chen, Chang, et al.
Publicado: (2023)

Impact of lifestyle and psychological stress on the development of early onset breast cancer
por: Li, Ping, et al.
Publicado: (2016)

Identification of potential key genes for HER-2 positive breast cancer based on bioinformatics analysis
por: Lin, Yuxiang, et al.
Publicado: (2020)

Hamartoma of the breast in a man: A rare case report
por: Li, Mengxin, et al.
Publicado: (2019)

Case report: 5-year progression free survival and complete liver response in a patient with metastatic breast cancer treated with everolimus plus exemestane
por: Krasniqi, Eriseld, et al.
Publicado: (2020)

Expression analysis of E-cad and vascular endothelial growth factor in triple-negative breast cancer patients of different ethnic groups in western China
por: Jiang, Weihua, et al.
Publicado: (2017)

Comparison of outcomes of surgeon-performed intraoperative ultrasonography-guided wire localization and preoperative wire localization in nonpalpable breast cancer patients undergoing breast-conserving surgery: A retrospective cohort study
por: Shin, Young Duck, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_v5ik8gkaaljksfkjidbaucq0jd